MediBuddy

Bengaluru, India Founded: 2013 • Age: 13 yrs Listed Acquired By DocsApp
Online platform offering multiple healthcare services
Request Access
Report Incorrect Data
Page last updated

About MediBuddy

MediBuddy is a publicly listed company based in Bengaluru (India) founded in 2013 by Enbasekar D and Satish Kannan, and was acquired by DocsApp in June 2020. MediBuddy has raised $199.22 million across 15 funding rounds from investors including DeNA, Bessemer Venture Partners and DocsApp. The company has 52 employees. MediBuddy has completed 2 acquisitions, including Clinix and MediBuddy VHealth. MediBuddy was last valued at $418.14 million in February 2023. Its chief executive, as recorded, is Satish Kannan. Its website medibuddy.in draws about 1.4 million monthly visits. Its Indian entity Medi Assist Healthcare Services Limited reported revenue of ₹924 Cr. Its focus areas include HealthTech, Healthcare Booking Platforms and Diversified. Its competitors include Practo, API Holdings and Mfine; 3 of its 3 listed competitors have raised funding.

Company details

Online platform offering multiple healthcare services. The platform enables users to search for healthcare providers and schedule follow-ups with doctors across multiple medical specialties. Also, it enables users to access medicine delivery, lab tests, health check-up, and insurance services.

  • Headquarters Bengaluru, India
  • Employees 52
  • Founders Enbasekar D, Satish Kannan
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Finance · Insurance
  • Phone
    •••• ••••
  • Website medibuddy.in
  • Social LinkedIn X Facebook
  • Acquired by DocsApp (Jun 2020)
  • Legal Name Medi Assist Healthcare Services Limited
  • Date of Incorporation 07 Jun, 2000
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Digital Health & Telemedicine
Key Metrics
  • Market Cap
    ₹2,156 Cr

    MEDIASSIST · NSE

  • Share Price
    ₹284.15

    -1.54% today

  • Revenue
    ₹905 Cr

    FY 2025-26 · +25.1% YoY

  • EBITDA
    ₹160 Cr

    Margin 17.7%

  • Net Profit
    ₹96.22 Cr

    FY 2025-26 · +9.3% YoY

  • P/E (TTM)
    22.1x

    P/B 2.7x

  • Total Equity Funding
    $199.22M (USD)

    in 15 rounds

  • Latest Funding Round
    $5.9M (USD), Series C

    Jan 2026

  • Investors
    DeNA

    & 52 more

  • Employee Count
    52
  • Investments & Acquisitions
    Clinix

    & 1 more

  • Acquired by
    DocsApp

    (Jun 2020)

Apps and channels of MediBuddy

MediBuddy publishes 1 mobile app with over 5M+ downloads.

MediBuddy-Doctor Medicine ABHA
Google Play Medical Everyone Free 5M+ downloads
Developer: Online Doctor, Lab Test, Health Check up
View on Google Play

Funding Insights of MediBuddy

MediBuddy has successfully raised a total of $199.22M across 15 strategic funding rounds. The most recent funding activity was a Series C round of $5.9 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $199.22M
  • Total Rounds 15
  • Last Round Series C — $5.9M
  • First Round $232,937

    (Mar 2014)

  • Investors Count 52

Latest 10 of 15 funding rounds of MediBuddy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2026$5.9MSeries C–BlackSoil
Alteria Capital, Bessemer Venture Partners
May 2024$8.4MDebt – Venture––
Innoven Capital, Alteria Capital
Feb 2023$18.86MSeries C$418.14MZenith Investment Partners
Quadria Capital, Lightrock
Feb 2022$125MSeries C$334.01MQuadria Capital, Lightrock India
Bessemer Venture Partners, JAFCO Asia
Oct 2021$885,859Series B$•••••Stride Ventures
Innoven Capital
Jun 2021$3.43MDebt – Venture––
Stride Ventures
Feb 2021$3.43MDebt – Conventional––
Innoven Capital
May 2020$40MSeries B$•••••InvAscent, Ales
JAFCO Asia, FinSight
Oct 2018$20,412Angel Round$•••••Ashok Kumar Sarojananjundan
–
Oct 2017$6.03MSeries A$•••••Bessemer Venture Partners
Rebright Partners, Milliways Ventures
Valuation history
DateValuationStage
Feb 2023$418.14M••••••••
Feb 2022$334.01M••••••••
Oct 2021$•••••••••••••
May 2020$•••••••••••••
Oct 2018$•••••••••••••
Oct 2017$•••••••••••••
May 2017$•••••••••••••
May 2016$•••••••••••••
Premium access

Full valuation and stage history of MediBuddy

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $418.14M (Feb 2023). 53 investors in total: 30 institutional and 23 angel.

Investors in MediBuddy

MediBuddy has secured backing from 53 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include DeNA, Bessemer Venture Partners and DocsApp.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
InnoVen Capital
Venture debt financing is extended to companies across multiple sectors.
2008innovencapital.comMumbai, India
Alteria Capital
Venture debt funding and structured finance for innovative startups in India.
2018alteriacapital.comMumbai, India
Quadria Capital
Healthcare private equity investments focused on Asian markets.
2012quadriacapital.comSingapore, Singapore
Lightrock
Investments are directed toward growth-stage companies generating scalable impact.
2009lightrock.comLondon, United Kingdom
Stride Ventures
Venture debt is provided to growth-stage companies for business scaling.
strideventures.globalDelhi, India
Bessemer Venture Partners
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
1911bvp.comRedwood City, United States
JAFCO Asia
Investments in early-stage tech startups are made by JAFCO Asia.
jafcoasia.comSingapore, Singapore
Rebright Partners
Early-stage venture capital firm focusing on Asia regions.
2008rebrightpartners.com
FinSight
Tech investment firm offering venture capital and support to startups in AI and related fields.
2013finsightvc.comNew York, United States
Mitsui Sumitomo Insurance Venture Capital
Seed to late-stage venture capital investments are made in Japan.
msivc.co.jpTokyo, Japan
Premium access

Investor details for MediBuddy

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Medi Assist Healthcare Services Limited (MediBuddy)

Medi Assist Healthcare Services Limited is the primary company behind MediBuddy. The boards of the 2 registered companies of MediBuddy currently have 14 directors; the longest-serving is Vikram Jit Singh Chhatwal, appointed in 2010. 35 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vikram Jit Singh Chhatwal
DIN 01606329
Director15 Nov 201015 yrs 11 moMedi Assist Healthcare Services Limited
Enbasekar Dinadayalane
DIN 06639696
Director31 Jul 201313 yrs 2 moPhasorz Technologies Private Limited
Satish Kannan
DIN 06639711
Managing Director31 Jul 201313 yrs 2 moPhasorz Technologies Private Limited
Vishal Vijay Gupta
DIN 01913013
Director21 Aug 20188 yrs 2 moPhasorz Technologies Private Limited
Satish Gidugu
DIN 06643677
Whole-time director01 Apr 20206 yrs 6 moMedi Assist Healthcare Services Limited
Tirunelveli Padmanabhan Devarajan
DIN 03473633
Nominee Director08 Jan 20215 yrs 9 moPhasorz Technologies Private Limited
Ritu Niraj Anand
DIN 00363699
Director05 Mar 20215 yrs 7 moMedi Assist Healthcare Services Limited
Sunil Kumar Thakur
DIN 03266370
Nominee Director25 Jun 20224 yrs 3 moPhasorz Technologies Private Limited
Madhavan Ganesan
DIN 01674529
Director14 Nov 20241 yr 11 moMedi Assist Healthcare Services Limited
Narain Duraiswami
DIN 03310642
Director14 Nov 20241 yr 11 moMedi Assist Healthcare Services Limited
Alamelu Lakshmanachary Thatra
DIN 07628279
Director14 Nov 20241 yr 11 moMedi Assist Healthcare Services Limited
Ashwinraghav
DIN 10908920
Director05 Feb 20251 yr 8 moMedi Assist Healthcare Services Limited
Samir Rajendra Abhyankar
DIN 10081649
Nominee Director05 Jun 20251 yr 4 moPhasorz Technologies Private Limited
Sunita Rebecca Cherian
DIN 10188170
Director06 Feb 20268 moMedi Assist Healthcare Services Limited

People of MediBuddy

97 people are tracked at MediBuddy (27 in leadership, 70 in team); the tracked headcount is 52.

NameRoleGroup
Enbasekar D
Co-Founder & CTOLeadership
Satish Kannan
Co-Founder & CEOLeadership
Mohammed Irfan
Director Of EngineeringLeadership
Shubham Sarawagi
Director - Insurer Wellness BusinessLeadership
Sonal Gupta
Vice PresidentLeadership
Sidhartha Mehra
Chief Financial OfficerLeadership
Shanawar Hasnain
Director Of EngineeringLeadership
Swetha Priya
Senior DirectorLeadership
Divya Saurabh
Associate Director - Sales And Partnerships (karnataka, AP & Telangana)Leadership
Sivareena S.l.
VP And P&l Head - Strategic InitiativesLeadership
Anurag Bhatnagar
Senior Vice President & Business HeadLeadership
Karthik D R
Founder's OfficeLeadership
Jaspreet Marwa
Head Of Customer SupportLeadership
Pratik Chouhan
Associate Vice PresidentLeadership
Kuldeep Singh
Senior Vice President Of EngineeringLeadership
Joel Fernandez
Senior DirectorLeadership
Manu Sankar Das
Senior Director - Brand Marketing, Media Buying & Consumer InsightsLeadership
Ashok Sn
Chief Strategy And Distribution OfficerLeadership
Sabyasachi Das
Chief - Affinity BusinessLeadership
Adnan Sayed
Associate Director Of SalesLeadership

77 more people are available in the full profile.

Premium access

Complete people profiles for MediBuddy

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of MediBuddy

MediBuddy is a publicly listed company on the NSE with ticker symbol MEDIASSIST in India, operating in the Miscellaneous sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: MEDIASSIST
  • Listed entityMedi Assist Healthcare Services Limited
  • Exchange sectorMiscellaneous

Financials of MediBuddy

Exchange-reported figures of Medi Assist Healthcare Services Limited, the listed company behind MediBuddy (NSE: MEDIASSIST).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹905 Cr
+25.1% YoY
EBITDA
₹160 Cr
+4.1% YoY
Profit After Tax
₹96.22 Cr
+9.3% YoY
Net Worth
₹839 Cr
+54.9% YoY
Total Assets
₹952 Cr
+18.8% YoY
Total Debt
₹54.40 Cr
-73.3% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue905723635505394323319
Revenue growth+25.1%+14.0%+25.7%+28.2%+22.0%+1.3%-
EBITDA16015411011891.1964.0177.13
EBITDA margin+17.7%+21.3%+17.4%+23.4%+23.2%+19.8%+24.2%
Profit before tax80.3511282.2710281.4449.3158.75
Net profit96.2288.0080.4870.0561.9323.8333.30
Net profit margin+10.6%+12.2%+12.7%+13.9%+15.7%+7.4%+10.5%
EPS (₹)12.1412.899.5310.769.337,101.359,601.67
Balance sheet
Total assets952801534436378336337
Net worth839541472377337290213
Total debt54.4020426.3330.6827.4835.30114
Cash & bank86.3418516421262.5311539.13
Net working capital11.611241001338.5559.7229.59
Cash flow
Cash from operations11813866.3881.0864.4013918.65
Cash from investing(158)(218)(54.64)(10.21)(82.90)(60.80)(22.22)
Cash from financing12.20112(14.76)(31.53)(30.29)(9.79)(11.75)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue237242240233191189186181
Revenue growth (YoY)+24.1%+28.1%+28.9%+28.6%+13.6%---
Other income10.502.737.562.287.297.774.476.42
EBITDA48.0248.2630.4239.7242.0140.7039.6938.46
EBITDA margin+20.3%+19.9%+12.7%+17.1%+22.0%+21.5%+21.3%+21.3%
Depreciation21.8520.9521.1320.9314.1114.1114.4213.54
Interest1.762.148.397.594.674.362.491.79
Profit before tax34.9127.908.4613.4830.5230.0027.2529.55
Tax7.31(26.57)4.345.407.888.42(2.73)8.53
Net profit27.6054.474.128.0822.6421.5829.9821.02
EPS (₹)3.717.330.511.123.163.044.182.97
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue22515110863.7954.6554.0161.89
Revenue growth+49.7%+38.9%+70.0%+16.7%+1.2%-12.7%-
EBITDA80.9959.3215.053.2813.4912.1434.54
EBITDA margin+35.9%+39.4%+13.9%+5.1%+24.7%+22.5%+55.8%
Profit before tax68.7744.5625.5118.9618.0742.7048.97
Net profit52.0331.7633.4115.9915.8531.2936.56
Net profit margin+23.1%+21.1%+30.8%+25.1%+29.0%+57.9%+59.1%
EPS (₹)7.184.712.772.412.699,463.7810,274.72
Balance sheet
Total assets498260218171173171155
Net worth48923021616816716476.02
Total debt4.8015.380.942.844.585.5878.30
Cash & bank23.3635.7224.2424.495.8839.425.55
Net working capital16.9856.2248.8639.9343.5254.3914.81
Cash flow
Cash from operations59.2762.6639.8724.16(8.31)24.35(13.99)
Cash from investing(253)(49.12)(49.42)7.21(4.36)28.22(0.48)
Cash from financing193(11.81)0.18(15.07)(19.41)(2.60)(1.71)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue58.9863.5657.4360.7643.7042.5534.3339.48
Revenue growth (YoY)+35.0%+49.4%+67.3%+53.9%+27.7%---
Other income7.035.153.863.262.360.631.813.15
Total expenses42.3239.6039.8435.7529.2722.4426.9722.16
EBITDA16.6623.9617.5925.0114.4320.117.3617.32
EBITDA margin+28.2%+37.7%+30.6%+41.2%+33.0%+47.3%+21.4%+43.9%
Depreciation4.885.135.135.005.074.994.694.75
Interest1.114.580.620.460.870.960.850.90
Profit before tax17.7019.4015.7022.8110.8514.793.6314.82
Tax4.554.913.875.182.834.06(0.04)4.69

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 23 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue237242240233191189186181
Revenue growth (YoY)+24.1%+28.1%+28.9%+28.6%+13.6%---
Other income10.502.737.562.287.297.774.476.42
EBITDA48.0248.2630.4239.7242.0140.7039.6938.46
EBITDA margin+20.3%+19.9%+12.7%+17.1%+22.0%+21.5%+21.3%+21.3%
Depreciation21.8520.9521.1320.9314.1114.1114.4213.54
Interest1.762.148.397.594.674.362.491.79
Profit before tax34.9127.908.4613.4830.5230.0027.2529.55
Tax7.31(26.57)4.345.407.888.42(2.73)8.53
Net profit27.6054.474.128.0822.6421.5829.9821.02
EPS (₹)3.717.330.511.123.163.044.182.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue905723635505394323319
Revenue growth+25.1%+14.0%+25.7%+28.2%+22.0%+1.3%-
Other income19.6423.7618.3214.0221.6122.5511.82
Total expenses744569525387303259241
Employee cost0.00306255198156143135
EBITDA16015411011891.1964.0177.13
EBITDA margin+17.7%+21.3%+17.4%+23.4%+23.2%+19.8%+24.2%
Depreciation77.1355.7843.0826.7728.4131.5226.51
Interest22.5710.303.172.992.955.733.69
Profit before tax80.3511282.2710281.4449.3158.75
Tax(8.95)20.1913.0928.3017.2223.0324.19
Net profit96.2288.0080.4870.0561.9323.8333.30
Net profit margin+10.6%+12.2%+12.7%+13.9%+15.7%+7.4%+10.5%
EPS (₹)12.1412.899.5310.769.337,101.359,601.67
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital37.3135.2635.1134.4334.430.040.21
Reserves & surplus764468398301258248212
Shareholders' funds (net worth)839541472377337290213
Minority interest13.5010.699.597.062.162.162.16
Secured loans0.001500.000.000.000.0019.45
Unsecured loans54.4053.6226.3330.6827.4835.3095.05
Total debt54.4020426.3330.6827.4835.30114
Total liabilities952801534436378336337
Assets
Gross block945533437319237231233
Net block63930624617198.70119138
Capital work in progress19.443.873.010.006.460.691.38
Investments15827476.8344.0020111171.92
Inventories0.000.000.000.000.000.000.00
Sundry debtors28722117912711912167.88
Cash & bank balances86.3418516421262.5311539.13
Loans & advances59.4173.9166.1960.7351.5032.81144
Total current assets432480409399233269251
Total current liabilities421357308267224209222
Net working capital11.611241001338.5559.7229.59
Total assets952801534436378336337
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash83.0150.9353.9414.6063.39(5.46)9.87
Net cash from operating activities11813866.3881.0864.4013918.65
Net cash from investing activities(158)(218)(54.64)(10.21)(82.90)(60.80)(22.22)
Net cash from financing activities12.20112(14.76)(31.53)(30.29)(9.79)(11.75)
Net change in cash(28.38)32.09(3.02)39.35(48.79)68.85(15.32)
Closing cash86.3418516421262.5311539.13
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+25.1%+14.0%+25.7%+28.2%+22.0%+1.3%-
EBITDA growth+4.1%+39.8%-6.7%+29.5%+42.5%-17.0%-
PBT growth-28.1%+35.8%-19.6%+25.7%+65.2%-16.1%+42.3%
Net income growth+9.3%+9.3%+14.9%+13.1%+159.9%-28.4%-
Revenue CAGR (3Y)+21.5%+22.5%+25.3%+16.6%+12.5%--
EBITDA CAGR (3Y)+10.8%+19.1%+19.9%+15.3%+12.3%--
Profitability & leverage
Net income margin+9.9%+12.7%+10.9%+14.7%+16.3%+8.1%+10.9%
Return on capital employed-+18.6%+22.5%+26.2%+23.8%+18.2%+19.0%
Return on net worth-+18.1%+19.5%+20.8%+20.5%+9.5%+16.1%
Debt / equity-0.230.070.080.100.300.49
Long-term debt / equity-0.070.040.050.070.120.17
Interest cover27.1010.484.723.274.7017.647.29
Efficiency & per share
Fixed asset turnover-1.491.681.821.681.391.43
Inventory turnover-0.000.000.000.000.000.00
Debtors turnover-3.624.154.113.283.424.03
EPS (₹)12.1412.899.5310.769.337,101.359,601.67
Dividend per share (₹)2.000.002.501.891.890.000.00
Book value per share (₹)0.0071.4061.6848.6942.4466,981.8959,010.28
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue58.9863.5657.4360.7643.7042.5534.3339.48
Revenue growth (YoY)+35.0%+49.4%+67.3%+53.9%+27.7%---
Other income7.035.153.863.262.360.631.813.15
Total expenses42.3239.6039.8435.7529.2722.4426.9722.16
EBITDA16.6623.9617.5925.0114.4320.117.3617.32
EBITDA margin+28.2%+37.7%+30.6%+41.2%+33.0%+47.3%+21.4%+43.9%
Depreciation4.885.135.135.005.074.994.694.75
Interest1.114.580.620.460.870.960.850.90
Profit before tax17.7019.4015.7022.8110.8514.793.6314.82
Tax4.554.913.875.182.834.06(0.04)4.69
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue22515110863.7954.6554.0161.89
Revenue growth+49.7%+38.9%+70.0%+16.7%+1.2%-12.7%-
Other income14.637.6722.1721.7113.5144.5924.89
Total expenses14491.2793.3760.5141.1641.8727.35
Employee cost0.0024.7620.5119.6415.1625.3414.49
EBITDA80.9959.3215.053.2813.4912.1434.54
EBITDA margin+35.9%+39.4%+13.9%+5.1%+24.7%+22.5%+55.8%
Depreciation20.3218.8011.525.708.4710.849.89
Interest6.533.630.190.330.463.190.57
Profit before tax68.7744.5625.5118.9618.0742.7048.97
Tax16.7811.356.052.37(0.43)7.6911.98
Net profit52.0331.7633.4115.9915.8531.2936.56
Net profit margin+23.1%+21.1%+30.8%+25.1%+29.0%+57.9%+59.1%
EPS (₹)7.184.712.772.412.699,463.7810,274.72
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital37.3135.2635.1134.4334.430.040.04
Reserves & surplus40815013585.2712515970.40
Shareholders' funds (net worth)48923021616816716476.02
Secured loans0.0010.000.000.000.000.0019.45
Unsecured loans4.805.380.942.844.585.5858.85
Total debt4.8015.380.942.844.585.5878.30
Total liabilities498260218171173171155
Assets
Gross block15414781.9076.2562.8560.7956.84
Net block52.5264.5117.3723.249.5515.8922.55
Capital work in progress19.443.873.010.006.460.691.38
Investments17312013395.2810394.0487.75
Inventories0.000.000.000.000.000.000.00
Sundry debtors33.8923.9315.4712.8135.7630.669.93
Cash & bank balances23.3635.7224.2424.495.8839.425.55
Loans & advances12.4767.8743.0228.8124.2320.7659.23
Total current assets69.7212882.7366.1165.8790.8474.71
Total current liabilities52.7471.3033.8726.1822.3536.4559.90
Net working capital16.9856.2248.8639.9343.5254.3914.81
Total assets498260218171173171155
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash12.0910.3619.723.4335.51(14.45)1.72
Net cash from operating activities59.2762.6639.8724.16(8.31)24.35(13.99)
Net cash from investing activities(253)(49.12)(49.42)7.21(4.36)28.22(0.48)
Net cash from financing activities193(11.81)0.18(15.07)(19.41)(2.60)(1.71)
Net change in cash(0.73)1.73(9.37)16.30(32.08)49.96(16.17)
Closing cash23.3635.7224.2424.495.8839.425.55
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+49.7%+38.9%+70.0%+16.7%+1.2%-12.7%-
EBITDA growth+36.5%+294.2%+358.8%-75.7%+11.1%-64.9%-
PBT growth+54.3%+74.7%+34.6%+4.9%-57.7%-12.8%+517.5%
Net income growth+63.8%-4.9%+108.9%+0.9%-49.3%-14.4%-
Revenue CAGR (3Y)+52.3%+40.2%+26.2%+1.0%+1.3%--
EBITDA CAGR (3Y)+191.2%+63.8%+7.4%-54.4%-1.1%--
Profitability & leverage
Net income margin+23.1%+22.1%+18.0%+26.0%+33.9%+64.8%+59.8%
Return on capital employed-+20.2%+24.4%+11.2%+8.9%+25.0%+32.6%
Return on net worth-+14.9%+17.4%+9.9%+9.6%+26.1%+43.4%
Debt / equity-0.040.010.020.030.350.84
Long-term debt / equity-0.030.000.010.020.040.03
Interest cover10.768.965.38-13.649.16245.382.31
Efficiency & per share
Fixed asset turnover-1.321.370.920.880.921.21
Inventory turnover-0.000.000.000.000.000.00
Debtors turnover-7.647.672.631.652.662.57
EPS (₹)7.184.712.772.412.699,463.7810,274.72
Dividend per share (₹)2.000.002.501.891.890.000.00
Book value per share (₹)0.0026.2324.2417.3823.1342,861.3519,566.11

Investments & Acquisitions by MediBuddy

MediBuddy has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Clinix and MediBuddy VHealth.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
MediBuddy VHealth
Various healthcare services are provided via an online subscription platform.
vhealth.ioDelhi, India2008Feb 2023••••
Clinix
Online consultations with multi-specialty doctors are facilitated via digital platforms.
clinix.co.inHyderabad, India2021Jul 2022••••
Premium access

Complete acquisition details for MediBuddy

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of MediBuddy

7 dated milestones of MediBuddy across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded MediBuddy is founded.
  2. Funding First funding round of $233K.
  3. Milestone Reaches Minicorn status.
  4. Exit Acquired by DocsApp.
  5. Acquisition Acquires Clinix.
  6. Acquisition Acquires MediBuddy VHealth.
  7. Funding Latest funding round, Series C, of $5.9M.

Competitors of MediBuddy

MediBuddy has 3 listed competitors in our database, 3 of them funded. They include Practo, API Holdings and Mfine.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Practo
practo.com2008Bengaluru, India$227.88M
Doctor appointments are booked and healthcare professionals are consulted online.
API Holdings
apiholdings.in2012Mumbai, India$1.19B221
Digital healthcare tools are offered for pharmacies and clinics management.
Mfine
mfine.co2017Bengaluru, India$87.66M258
Provider of online doctor consultations, at-home lab tests, and health packages
Premium access

Detailed competitors of MediBuddy

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MediBuddy

The website of MediBuddy (medibuddy.in) receives about 1.4M visits a month and ranks #38,660 among all websites worldwide, #2,447 in Insurance.

  • Monthly visits
    1.4M

    ▼ 1.5% vs previous month

  • Unique visitors
    720.8K

    per month

  • Global rank
    #38,660

    among all websites

  • Category rank
    #2,447

    Finance · Insurance

Similar websites

Websites whose visitors overlap most with MediBuddy. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Medi Assist TPA
mediassisttpa.in
100%
#143,942View details
Medi Assist
mediassist.in
81%
1.9M#23,387View details
Truemeds
truemeds.in
79%
5.5M#12,844View details
Apollo 24|7
apollo247.com
78%
2.5M#26,447View details
Health India TPA Services
healthindiatpa.com
75%
106.7K#416,909View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for MediBuddy

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Digital Health & Telemedicine

2 companies that operate in the same segment as MediBuddy (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Tata 1mg
Provider of an online pharmacy with doctor listing and teleconsultation services
2015Delhi, Delhi, IndiaUSD 230.8 MUSD 328.97 M5,212
SastaSundar
An online marketplace for healthcare products is operated.
2011Kolkata, West Bengal, IndiaUSD 38.26 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Medibuddy

MediBuddy Appoints Former Swiggy, Flipkart Executive Shalabh Shrivastava as Head of Operations
Entrackr • 1 month ago
Broker’s Call: Medi Assist Healthcare Services (Buy) - The HinduBusinessLine
Thehindubusinessline • 1 month ago
Paramount TPA to merge with Medi Assist Insurance TPA - The Economic Times
Economic Times • 9 months ago
Medi Assist says subsidiary Paramount TPA faced cyber incident; systems restored - CNBC TV18
CNBCTV18 • 11 months ago
Medi Assist raises ₹198 crore from MIT and affiliate through preferential issue of 37 lakh shares - CNBC TV18
CNBCTV18 • 1 year ago
Medi Assist Healthcare Services shares rally 7% after Rs 578 crore block deal - The Economic Times
Economic Times • 1 year ago
Bessemer Venture Partners wraps up dream exit as portfolio firm taps new backer
VCCircle • 1 year ago
Bessemer India likely to sell up to 4% stake in Medi Assist via ₹560-crore block deal - CNBC TV18
CNBCTV18 • 1 year ago
Medi Assist Healthcare Services consolidated net profit rises 19.02% in the June 2025 quarter | Capital Market News - Business Standard
Business Standard • 1 year ago
Medi Assist Q1 net profit rises 19% to ₹22 crore on improved EBITDA, steady revenue growth - CNBC TV18
CNBCTV18 • 1 year ago
Premium access

Complete news archive for MediBuddy

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MediBuddy

MediBuddy was founded in 2013 and raised its 1st funding round 1 year after it was founded.

MediBuddy is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Satish Kannan is the CEO of MediBuddy, as recorded in our data. They have also founded this company.

MediBuddy is a funded company, having raised a total of $199.22M across 15 funding rounds to date. The company's 1st funding round was a Series A of $6.03M, raised on Mar 2014.

MediBuddy has 52 employees.

The primary company behind MediBuddy, Medi Assist Healthcare Services Limited, reported revenue of ₹924 Cr for FY 2026, up 25% year on year.

Online platform offering multiple healthcare services. The platform enables users to search for healthcare providers and schedule follow-ups with doctors across multiple medical specialties. Also, it enables users to access medicine delivery, lab tests, health check-up, and insurance services.

MediBuddy's top competitors include Practo, API Holdings and Mfine.

Yes, MediBuddy is publicly traded on NSE under the ticker symbol MEDIASSIST.

MediBuddy has made 2 acquisitions, including Clinix, and MediBuddy VHealth.

MediBuddy has 53 investors. Key investors include DeNA, Bessemer Venture Partners, DocsApp, Quadria Capital, and Alteria Capital.

The valuation of MediBuddy is $418.14M as of Feb 2023.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available